- Home
- GSAT vs AXSM Comparison
GSAT vs AXSM Comparison
Compare GSAT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GSAT | AXSM |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 12.0B |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GSAT | AXSM |
|---|---|---|
| Price | $79.91 | $241.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | $70.50 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 1.4M | 632.7K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.58 | 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $112,660,000.00 | N/A |
| Revenue This Year | $10.31 | $57.24 |
| Revenue Next Year | $15.93 | $55.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.35 | $96.09 |
| 52 Week High | $84.70 | $260.19 |
Technical Indicators
Market Signals| Indicator | GSAT | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 59.02 |
| Support Level | $56.44 | $148.87 |
| Resistance Level | $82.34 | N/A |
| Average True Range (ATR) | 1.38 | 8.88 |
| MACD | -0.36 | -0.97 |
| Stochastic Oscillator | 30.33 | 63.58 |
Price Performance
Historical ComparisonAbout GSAT Globalstar Inc.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.